Author

Zaigham Abbas Rizvi

Translational Health Science and Technology InstituteORCID 0000-0001-7850-5672Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Amit AwasthiiD· 1 shared Dipanjali Sinha· 1 shared Divya GuptaiD· 1 shared Krishnan Harinivas HarshaniD· 1 shared Manas Ranjan Tripathy· 1 shared Mercy RophinaiD· 1 shared Paras SehgaliD· 1 shared Sanjeev JainiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Amit AwasthiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologybioRxivPreprintMay 31, 2022

Anti-COVID-19 Activity of FDA Approved Drugs through RNA G-quadruplex Binding

Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi…·Shantanu Chowdhury

This study identifies FDA-approved drugs that bind G-quadruplexes in SARS-CoV-2 genomes, showing significant inhibition of viral replication in hamsters and cell cultures comparable to Remdesivir.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky